North American Neuromodulation Society


NANS strives to continually be engaged in advocacy activities that help promote the field of Neuromodulation. Through our Advocacy Committee and partner organizations, NANS reviews and works on programs and projects related to promoting the field of Neuromodulation. In addition, NANS collaborates with key stakeholders to ensure that patients have satisfactory access to Neuromodulation therapies as a treatment option and that the therapy is used effectively and appropriately. The group also maintains liaison with other key stakeholders, including: industry, government institutions and other interested/related parties to advocate for Neuromodulation as a treatment modality.

The NANS Advocacy and Policy Committee has worked tirelessly through various channels, including our association with the Multi-Society Pain Working Group, the AMA Specialty Section Council and our members’ own initiatives, to keep our members informed of activities and potential legislation that may impact the field of neuromodulation. One of the main benefits the Advocacy and Policy Committee has been providing is the drafting of a series of letters addressed to insurance carriers advocating for continued or improved coverage for neuromodulation treatments. Currently, we have submitted letters on NANS’ behalf regarding coverage for HF10 therapy, DRG and DBS. Samples of the letters are available in the resource center for members behind the member login page.  Members can feel free to use the letters as a guide in crafting your own letters as well, should you need to do so for any particular purpose.

Please look for regular updates from the Advocacy and Policy Committee in the NANS Newsletter as well as via e-mail.


NANS has also started a PR effort both independently and in collaboration with other specialty societies. Together, we are working on publicizing news articles and events that are taking place within the field of Neuromodulation. Currently, NANS is working on a PR pilot program in the state of California that consists of five test markets focusing on alternatives to opioids. 

PR plays a significant role in our advocacy efforts on behalf of patients and practitioners alike. NANS is developing an expanded page featuring news articles and other features where Neuromodulation is the primary focus. NANS encourages its members to submit articles of interest as well as any success stories from patients who have benefited from this therapy. Please submit all materials to NANS at

To learn more about how you can advocate for Neuromodulation as well as contribute to our PR efforts, please view the video posted here.

The video was produced in collaboration with the American Society of Interventional Pain Physicians (ASIPP).


WIKISTIM is a searchable database being populated with data published in the field of neuromodulation. The goals of WIKISTIM are to improve patient care and the quality of research reports, foster communication, reveal research needs, and support the practice of evidence–based medicine.

NANS Events   

  • Jan. 13-15, 2022

    NANS 25th Annual Meeting
    Walt Disney World Swan & Dolphin Resort
    Orlando, FL
    Learn more.

Contains 0 items
Subtotal: $0.00